Identification of Spindle and Kinetochore-Associated Family Genes as Therapeutic Targets and Prognostic Biomarkers in Pancreas Ductal Adenocarcinoma Microenvironment

Fogel, 2017, A multidisciplinary approach to pancreas cancer in 2016: a review., Am J Gastroenterol., 112, 537, 10.1038/ajg.2016.610

Wolfgang, 2013, Recent progress in pancreatic cancer., CA Cancer J Clin., 63, 318, 10.3322/caac.21190

Zeng, 2015, Cancer survival in China, 2003-2005: a population-based study., Int J Cancer., 136, 1921, 10.1002/ijc.29227

Bray, 2018, Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries., CA Cancer J Clin., 68, 394, 10.3322/caac.21492

Hidalgo, 2010, Pancreatic cancer., N Engl J Med., 362, 1605, 10.1056/NEJMra0901557

Singhi, 2019, Early detection of pancreatic cancer: opportunities and challenges., Gastroenterology., 156, 2024, 10.1053/j.gastro.2019.01.259

Kamisawa, 2016, Pancreatic cancer., Lancet., 388, 73, 10.1016/S0140-6736(16)00141-0

Mitchison, 2001, Mitosis: a history of division., Nat Cell Biol., 3, E17, 10.1038/35050656

Hanisch, 2006, Timely anaphase onset requires a novel spindle and kinetochore complex comprising Ska1 and Ska2., EMBO J., 25, 5504, 10.1038/sj.emboj.7601426

Gaitanos, 2009, Stable kinetochore-microtubule interactions depend on the Ska complex and its new component Ska3/C13Orf3., EMBO J., 28, 1442, 10.1038/emboj.2009.96

Welburn, 2009, The human kinetochore Ska1 complex facilitates microtubule depolymerization-coupled motility., Dev Cell., 16, 374, 10.1016/j.devcel.2009.01.011

Liu, 2019, A 6gene risk score system constructed for predicting the clinical prognosis of pancreatic adenocarcinoma patients., Oncol Rep., 41, 1521, 10.3892/or.2019.6979

Li, 2014, SKA1 over-expression promotes centriole over-duplication, centrosome amplification and prostate tumourigenesis., J Pathol., 234, 178, 10.1002/path.4374

Sun, 2014, Spindle and kinetochore-associated protein 1 is overexpressed in gastric cancer and modulates cell growth., Mol Cell Biochem., 391, 167, 10.1007/s11010-014-1999-1

Wang, 2017, Overexpression of spindle and kinetochore-associated protein 1 contributes to the progression of prostate cancer., Tumour Biol., 39, 10.1177/1010428317701918

Zhang, 2013, Spindle and kinetochore associated complex subunit 1 regulates the proliferation of oral adenosquamous carcinoma CAL-27 cells in vitro., Cancer Cell Int., 13, 10.1186/1475-2867-13-83

Qin, 2013, Effects of short interfering RNA-mediated gene silencing of SKA1 on proliferation of hepatocellular carcinoma cells., Scand J Gastroenterol., 48, 1324, 10.3109/00365521.2013.828774

Jiang, 2018, High expression of spindle and kinetochore- associated protein 1 predicts early recurrence and progression of non-muscle invasive bladder cancer., Cancer Biomarkers Section A Dis Markers., 22, 543, 10.3233/cbm-181202

Shen, 2016, SKA1 regulates the metastasis and cisplatin resistance of non-small cell lung cancer., Oncol Rep., 35, 2561, 10.3892/or.2016.4670

Shi, 2015, Lentivirus-mediated silencing of spindle and kinetochore-associated protein 1 inhibits the proliferation and invasion of neuronal glioblastoma cells., Mol Med Rep., 11, 3533, 10.3892/mmr.2015.3175

2015, Human genomics. The genotype-tissue expression (GTEx) pilot analysis: multitissue gene regulation in humans., Science., 348, 648, 10.1126/science.1262110

2013, The genotype-tissue expression (GTEx) project., Nat Genet., 45, 580, 10.1038/ng.2653

2017, Electronic address aadhe, cancer genome atlas research N. Integrated genomic characterization of pancreatic ductal adenocarcinoma., Cancer Cell., 32, 185, 10.1016/j.ccell.2017.07.007

Anders, 2010, Differential expression analysis for sequence count data., Genome Biol., 11, 10.1186/gb-2010-11-10-r106

Ritchie, 2015, limma powers differential expression analyses for RNA-sequencing and microarray studies., Nucleic Acids Res., 43, 10.1093/nar/gkv007

Klett, 2018, Identification and validation of a diagnostic and prognostic multi-gene biomarker panel for pancreatic ductal adenocarcinoma., Front Genet., 9, 10.3389/fgene.2018.00108

Sutaria, 2017, Expression profiling identifies the noncoding processed transcript of HNRNPU with proliferative properties in pancreatic ductal adenocarcinoma., Noncoding RNA., 3, 10.3390/ncrna3030024

Idichi, 2017, Regulation of actin-binding protein ANLN by antitumor miR-217 inhibits cancer cell aggressiveness in pancreatic ductal adenocarcinoma., Oncotarget., 8, 53180, 10.18632/oncotarget.18261

Yang, 2016, A novel MIF signaling pathway drives the malignant character of pancreatic cancer by targeting NR3C2., Cancer Res., 76, 3838, 10.1158/0008-5472.CAN-15-2841

Li, 2016, Genetic variations associated with gemcitabine treatment outcome in pancreatic cancer., Pharmacogenet Genomics., 26, 527, 10.1097/FPC.0000000000000241

Janky, 2016, Prognostic relevance of molecular subtypes and master regulators in pancreatic ductal adenocarcinoma., BMC Cancer., 16, 10.1186/s12885-016-2540-6

Moffitt, 2015, Virtual microdissection identifies distinct tumor- and stroma-specific subtypes of pancreatic ductal adenocarcinoma., Nat Genet., 47, 1168, 10.1038/ng.3398

Zhang, 2013, Integration of metabolomics and transcriptomics revealed a fatty acid network exerting growth inhibitory effects in human pancreatic cancer., Clin Cancer Res., 19, 4983, 10.1158/1078-0432.CCR-13-0209

Donahue, 2012, Integrative survival-based molecular profiling of human pancreatic cancer., Clin Cancer Res., 18, 1352, 10.1158/1078-0432.CCR-11-1539

Ishikawa, 2005, Experimental trial for diagnosis of pancreatic ductal carcinoma based on gene expression profiles of pancreatic ductal cells., Cancer Sci., 96, 387, 10.1111/j.1349-7006.2005.00064.x

Warde-Farley, 2010, The GeneMANIA prediction server: biological network integration for gene prioritization and predicting gene function., Nucleic Acids Res., 38, W214, 10.1093/nar/gkq537

von Mering, 2003, STRING: a database of predicted functional associations between proteins., Nucleic Acids Res., 31, 258, 10.1093/nar/gkg034

Szklarczyk, 2017, The STRING database in 2017: quality-controlled protein-protein association networks, made broadly accessible., Nucleic Acids Res., 45, D362, 10.1093/nar/gkw937

Mostafavi, 2008, GeneMANIA: a real-time multiple association network integration algorithm for predicting gene function., Genome Biol., 10.1186/gb-2008-9-s1-s4

Mootha, 2003, PGC-1alpha-responsive genes involved in oxidative phosphorylation are coordinately downregulated in human diabetes., Nat Genet., 34, 267, 10.1038/ng1180

Subramanian, 2005, Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles., Proc Natl Acad Sci USA., 102, 15545, 10.1073/pnas.0506580102

Liberzon, 2011, Molecular signatures database (MSigDB) 3.0., Bioinformatics., 27, 1739, 10.1093/bioinformatics/btr260

Liberzon, 2015, The Molecular signatures database (MSigDB) hallmark gene set collection., Cell Syst., 1, 417, 10.1016/j.cels.2015.12.004

Liu, 2020, Identification of F5 as a prognostic biomarker in patients with gastric cancer., Biomed Res Int., 2020, 10.1155/2020/9280841

Vasaikar, 2018, LinkedOmics: analyzing multi-omics data within and across 32 cancer types., Nucleic Acids Res., 46, D956, 10.1093/nar/gkx1090

Mermel, 2011, GISTIC2.0 facilitates sensitive and confident localization of the targets of focal somatic copy-number alteration in human cancers., Genome Biol., 12, 10.1186/gb-2011-12-4-r41

Yoshihara, 2013, Inferring tumour purity and stromal and immune cell admixture from expression data., Nat Commun., 4, 10.1038/ncomms3612

Li, 2017, TIMER: a web server for comprehensive analysis of tumor-infiltrating immune cells., Cancer Res., 77, e108, 10.1158/0008-5472.CAN-17-0307

Majeti, 2009, CD47 is an adverse prognostic factor and therapeutic antibody target on human acute myeloid leukemia stem cells., Cell., 138, 286, 10.1016/j.cell.2009.05.045

Kosmaczewska, 2001, Expression and functional significance of CTLA-4, a negative regulator of T cell activation., Arch Immunol Ther Exp (Warsz)., 49, 39

Gordon, 2017, PD-1 expression by tumour-associated macrophages inhibits phagocytosis and tumour immunity., Nature., 545, 495, 10.1038/nature22396

Barkal, 2018, Engagement of MHC class I by the inhibitory receptor LILRB1 suppresses macrophages and is a target of cancer immunotherapy., Nat Immunol., 19, 76, 10.1038/s41590-017-0004-z

Abad, 2014, Structural basis for microtubule recognition by the human kinetochore Ska complex., Nat Commun., 5, 10.1038/ncomms3964

Rice, 2008, Identification and functional analysis of SKA2 interaction with the glucocorticoid receptor., J Endocrinol., 198, 499, 10.1677/JOE-08-0019

Jeyaprakash, 2012, Structural and functional organization of the Ska complex, a key component of the kinetochore-microtubule interface., Mol Cell., 46, 274, 10.1016/j.molcel.2012.03.005

Chan, 2012, Aurora B controls kinetochore-microtubule attachments by inhibiting Ska complex-KMN network interaction., J Cell Biol., 196, 563, 10.1083/jcb.201109001

Dong, 2019, Long non-coding RNA ZFAS1 promotes proliferation and metastasis of clear cell renal cell carcinoma via targeting miR-10a/SKA1 pathway., Biomed Pharmacother Biomed Pharmacother., 111, 917, 10.1016/j.biopha.2018.12.143

Hu, 2019, SKA1 overexpression is associated with the prognosis of esophageal squamous cell carcinoma and regulates cell proliferation and migration., Int J Mol Med., 44, 1971, 10.3892/ijmm.2019.4343

Zhao, 2017, Knockdown of SKA1 gene inhibits cell proliferation and metastasis in human adenoid cystic carcinoma., Biomed Pharmacother Biomed Pharmacother., 90, 8, 10.1016/j.biopha.2017.03.029

Zhao, 2016, Expression of SKA1 and MMP-9 in primary salivary adenoid cystic carcinoma: correlation with tumor progression and patient prognosis., Acta Laryngol., 136, 575, 10.3109/00016489.2016.1142117

Tian, 2015, Downregulation of SKA1 gene expression inhibits cell growth in human bladder cancer., Cancer Biother Radiopharm., 30, 271, 10.1089/cbr.2014.1715

Wang, 2019, SKA1 promotes malignant phenotype and progression of glioma via multiple signaling pathways., Cancer Cell Int., 19, 10.1186/s12935-019-1047-z

Chen, 2018, SKA1 overexpression is associated with poor prognosis in hepatocellular carcinoma., BMC Cancer., 18, 10.1186/s12885-018-5119-6

Warner, 2019, DNA repair defects in prostate cancer: impact for screening, prognostication and treatment., BJU Int., 123, 769, 10.1111/bju.14576

Xie, 2018, CDK16 phosphorylates and degrades p53 to promote radioresistance and predicts prognosis in lung cancer., Theranostics., 8, 650, 10.7150/thno.21963

Mirza-Aghazadeh-Attari, 2018, DNA damage response and repair in colorectal cancer: defects, regulation and therapeutic implications., DNA Repair., 69, 34, 10.1016/j.dnarep.2018.07.005

Morton, 2010, Mutant p53 drives metastasis and overcomes growth arrest/senescence in pancreatic cancer., Proc Natl Acad Sci USA., 107, 246, 10.1073/pnas.0908428107

Xie, 2019, SKA2/FAM33A: a novel gene implicated in cell cycle, tumorigenesis, and psychiatric disorders., Genes Dis., 6, 25, 10.1016/j.gendis.2018.11.001

Ren, 2019, SKA2 mediates invasion and metastasis in human breast cancer via EMT., Mol Med Rep., 19, 515, 10.3892/mmr.2018.9623

Su, 2019, Upregulation of microRNA-520a-3p inhibits the proliferation, migration and invasion via spindle and kinetochore associated 2 in gastric cancer., Oncol Lett., 18, 3323, 10.3892/ol.2019.10663

Wang, 2015, The gene pair PRR11 and SKA2 shares a NF-Y-regulated bidirectional promoter and contributes to lung cancer development., Biochim Biophys Acta., 1849, 1133, 10.1016/j.bbagrm.2015.07.002

Zhang, 2012, Localization and function of the Ska complex during mouse oocyte meiotic maturation., Cell Cycle (Georgetown, Tex)., 11, 909, 10.4161/cc.11.5.19384

Sivakumar, 2014, The spindle and kinetochore-associated (Ska) complex enhances binding of the anaphase-promoting complex/cyclosome (APC/C) to chromosomes and promotes mitotic exit., Mol Biol Cell., 25, 594, 10.1091/mbc.E13-07-0421

Hu, 2020, SKA3 promotes lung adenocarcinoma metastasis through the EGFR-PI3K-Akt axis., Biosci Rep., 40, 10.1042/bsr20194335

Tang, 2019, Identification of hub genes to regulate breast cancer metastasis to brain by bioinformatics analyses., J Cell Biochem., 120, 9522, 10.1002/jcb.28228

Ramteke, 2015, Exosomes secreted under hypoxia enhance invasiveness and stemness of prostate cancer cells by targeting adherens junction molecules., Mol Carcinogenesis., 54, 554, 10.1002/mc.22124

Lanki, 2019, Toll-like receptor 1 predicts favorable prognosis in pancreatic cancer., PLoS One., 14, 10.1371/journal.pone.0219245

Zhang, 2013, Canonical wnt signaling is required for pancreatic carcinogenesis., Cancer Res., 73, 4909, 10.1158/0008-5472.can-12-4384

Wang, 2011, Cyclin dependent kinase 1 inhibitors: a review of recent progress., Curr Med Chem., 18, 2025, 10.2174/092986711795590110

Karp, 2010, Clinical activity of sequential flavopiridol, cytosine arabinoside, and mitoxantrone for adults with newly diagnosed, poor-risk acute myelogenous leukemia., Leukemia Res., 34, 877, 10.1016/j.leukres.2009.11.007

Karp, 2012, Randomized phase II study of two schedules of flavopiridol given as timed sequential therapy with cytosine arabinoside and mitoxantrone for adults with newly diagnosed, poor-risk acute myelogenous leukemia., Haematologica., 97, 1736, 10.3324/haematol.2012.062539

Zhang, 2017, Ska3 phosphorylated by Cdk1 binds Ndc80 and recruits Ska to kinetochores to promote mitotic progression., Curr Biol., 27, 1477, 10.1016/j.cub.2017.03.060

Hou, 2019, SKA3 Promotes tumor growth by regulating CDK2/P53 phosphorylation in hepatocellular carcinoma., Cell Death Dis., 10, 10.1038/s41419-019-2163-3

Gray, 2004, Identification of human polo-like kinase 1 as a potential therapeutic target in pancreatic cancer., Mol Cancer Ther., 3, 641, 10.1158/1535-7163.641.3.5

Chaisaingmongkol, 2017, Common molecular subtypes among asian hepatocellular carcinoma and cholangiocarcinoma., Cancer Cell., 32, 57, 10.1016/j.ccell.2017.05.009

Furukawa, 2006, AURKA is one of the downstream targets of MAPK1/ERK2 in pancreatic cancer., Oncogene., 25, 4831, 10.1038/sj.onc.1209494

Kent, 2017, Dosage-dependent copy number gains in E2f1 and E2f3 drive hepatocellular carcinoma., J Clin Invest., 127, 830, 10.1172/JCI87583

Evangelou, 2014, E2F transcription factors and digestive system malignancies: how much do we know?, World J Gastroenterol., 20, 10212, 10.3748/wjg.v20.i29.10212

Zhu, 2018, Thymidine kinase 1 silencing retards proliferative activity of pancreatic cancer cell via E2F1-TK1-P21 axis., Cell Prolif., 51, 10.1111/cpr.12428

Schild, 2009, PI3K signaling maintains c-myc expression to regulate transcription of E2F1 in pancreatic cancer cells., Mol Carcinogenesis., 48, 1149, 10.1002/mc.20569

Rodicker, 2001, Therapeutic efficacy of E2F1 in pancreatic cancer correlates with TP73 induction., Cancer Res., 61, 7052

Kumari, 2009, Effect of c-MYC and E2F1 gene silencing and of 5-azacytidine treatment on telomerase activity in pancreatic cancer-derived cell lines., Pancreatology., 9, 360, 10.1159/000212094

Hayes, 2014, MicroRNAs in cancer: biomarkers, functions and therapy., Trends Mol Med., 20, 460, 10.1016/j.molmed.2014.06.005

Yan, 2019, LncRNA FLVCR1-AS1 mediates miR-513/YAP1 signaling to promote cell progression, migration, invasion and EMT process in ovarian cancer., J Exp Clin Cancer Res., 38, 10.1186/s13046-019-1356-z

Wang, 2019, Long non-coding RNA LINC00525 promotes the stemness and chemoresistance of colorectal cancer by targeting miR-507/ELK3 axis., Int J Stem Cells., 12, 347, 10.15283/ijsc19041

Wang, 2020, Long non-coding RNA AFAP1-AS1 promotes proliferation and invasion in prostate cancer via targeting miR-512-3p., Gene., 726, 10.1016/j.gene.2019.144169

Liang, 2018, Gambogic acid inhibits melanoma through regulation of miR-199a-3p/ZEB1 Signalling., Basic Clin Pharmacol Toxicol., 123, 692, 10.1111/bcpt.13090

Duan, 2020, MiR-512-3p regulates malignant tumor behavior and multi-drug resistance in breast cancer cells via targeting Livin., Neoplasma., 67, 102, 10.4149/neo_2019_190106N18

Yu, 2010, miRNA-96 suppresses KRAS and functions as a tumor suppressor gene in pancreatic cancer., Cancer Res., 70, 6015, 10.1158/0008-5472.CAN-09-4531

Xia, 2018, MicroRNA-185 suppresses pancreatic cell proliferation by targeting transcriptional coactivator with PDZ-binding motif in pancreatic cancer., Exp Ther Med., 15, 657, 10.3892/etm.2017.5447

Neault, 2016, miR-137 modulates a tumor suppressor network-inducing senescence in pancreatic cancer cells., Cell Rep., 14, 1966, 10.1016/j.celrep.2016.01.068

Liu, 2015, microRNA-218 suppresses the proliferation, invasion and promotes apoptosis of pancreatic cancer cells by targeting HMGB1., Chin J Cancer Res., 27, 247, 10.3978/j.issn.1000-9604.2015.04.07

Li, 2018, Tumor-released exosomal circular RNA PDE8A promotes invasive growth via the miR-338/MACC1/MET pathway in pancreatic cancer., Cancer Lett., 432, 237, 10.1016/j.canlet.2018.04.035

Palangat, 2019, The splicing factor U2AF1 contributes to cancer progression through a noncanonical role in translation regulation., Genes Dev., 33, 482, 10.1101/gad.319590.118

The Cancer Genome Atlas Research Network, Wheeler, 2017, Comprehensive and integrative genomic characterization of hepatocellular carcinoma., Cell., 169, 1327, 10.1016/j.cell.2017.05.046

Chen, 2017, MicroRNA-29a induces loss of 5-hydroxymethylcytosine and promotes metastasis of hepatocellular carcinoma through a TET-SOCS1-MMP9 signaling axis., Cell Death Dis., 8, 10.1038/cddis.2017.142

Xiong, 2018, Profiles of immune infiltration in colorectal cancer and their clinical significant: a gene expression-based study., Cancer Med., 7, 4496, 10.1002/cam4.1745

Aran, 2015, Systematic pan-cancer analysis of tumour purity., Nat Commun., 6, 10.1038/ncomms9971

Duewell, 2014, RIG-I-like helicases induce immunogenic cell death of pancreatic cancer cells and sensitize tumors toward killing by CD8(+) T cells., Cell Death Differ., 21, 1825, 10.1038/cdd.2014.96

Wang, 2017, Infiltrating CD4/CD8 high T cells shows good prognostic impact in pancreatic cancer., Int J Clin Exp Pathol., 10, 8820

Masugi, 2019, Characterization of spatial distribution of tumor-infiltrating CD8(+) T cells refines their prognostic utility for pancreatic cancer survival., Modern Pathol., 32, 1495, 10.1038/s41379-019-0291-z

Wu, 2019, Identification of a nine-gene signature and establishment of a prognostic nomogram predicting overall survival of pancreatic cancer., Front Oncol., 9, 10.3389/fonc.2019.00996

Hiraoka, 2006, Prevalence of FOXP3+ regulatory T cells increases during the progression of pancreatic ductal adenocarcinoma and its premalignant lesions., Clin Cancer Res., 12, 5423, 10.1158/1078-0432.ccr-06-0369

Borst, 2018, CD4+ T cell help in cancer immunology and immunotherapy., Nat Rev Immunol., 18, 635, 10.1038/s41577-018-0044-0

Kennedy, 2008, Multiple roles for CD4+ T cells in anti−tumor immune responses., Immunol Rev., 222, 129, 10.1111/j.1600-065x.2008.00616.x

Fujiwara, 2005, Macrophages in inflammation., Curr Drug Targets Inflamm. Allergy., 4, 281, 10.2174/1568010054022024

Kobayashi, 2001, Immunopathogenesis of delayed−type hypersensitivity., Microscopy Res Technique., 53, 241, 10.1002/jemt.1090

Banchereau, 1998, Dendritic cells and the control of immunity., Nature., 392, 245, 10.1038/32588

Wculek, 2019, Dendritic cells in cancer immunology and immunotherapy., Nat Rev Immunol., 20, 7, 10.1038/s41577-019-0210-z

Collin, 2018, Human dendritic cell subsets: an update., Immunology., 154, 3, 10.1111/imm.12888

Merad, 2013, The dendritic cell lineage: ontogeny and function of dendritic cells and their subsets in the steady state and the inflamed setting., Annu Rev Immunol., 31, 563, 10.1146/annurev-immunol-020711-074950

Broz, 2014, Dissecting the tumor myeloid compartment reveals rare activating antigen-presenting cells critical for T cell immunity., Cancer Cell., 26, 638, 10.1016/j.ccell.2014.09.007

Hildner, 2008, Batf3 deficiency reveals a critical role for CD8α+ dendritic cells in cytotoxic T cell immunity., Science., 322, 1097, 10.1126/science.1164206